Combo Tx Better in HIV-Related LymphomaMedPage TodayAdding the monoclonal antibody rituximab (Rituxan) to chemotherapy improves outcomes for HIV patients diagnosed with non-Hodgkin's lymphoma. Note that, on the other hand, patients with HIV-associa…
Clinical Oncology NewsClinical ConundrumsClinical Oncology NewsTrue or False: The preliminary results of the open-label Phase II GAUSS trial of rituximab (Rituxan; Biogen Idec, Genentech) versus obinutuzumab (GA101, Roche) for relapsed follicular lymph…
AbD Serotec plans to launch series of novel anti-drug antibodiespharmabiz.comStarting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan) and Trastuzumab (Herceptin), AbD Serotec plans to expand this product catego…
Panel of HuCAL Anti-Drug Antibodies to be launched by AbD SerotecNews-Medical.netStarting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan ® ) and Trastuzumab (Herceptin ® ), AbD Serotec plans to expand this pr…
MorphoSys' Unit To Intorduce Series Of Novel Anti-drug Antibodies – Quick FactsRTT NewsStarting with the recent launch of fully human, recombinant antibodies binding Rituximab and Trastuzumab, AbD Serotec intends to expand this product category wit…
Study finds FDA-approved drug makes established cancer vaccine work betterWestmoreland County TimesA team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approv…
Ciência HojeMedicamento para transplantes renais reforça vacina contra cancro da mamaCiência HojeO medicamento daclizumab, que é geralmente usado para evitar a rejeição em transplantes renais, poderá agora ser o complemento da vacina contra o ca…
MidiaconFármaco para evitar rejeição pós-transplante potencializa vacina contra o …RCM PharmaO grupo de cientistas sugere que o medicamento daclizumab, já utilizado para evitar rejeição em transplantes renais, é eficaz ao esgotar células T r…
MidiaconVacina contra o cancro da mama pode ser reforçada com medicamento pós-transplantePT JornalO medicamento daclizumab, vocacionado para evitar rejeição em transplantes renais, demonstrou capacidade para esgotar células T reguladoras (Tregs) e…
MidiaconFármaco para evitar rejeição pós-transplante potencializa vacina contra o …POP – Portal de Oncologia PortugêsO grupo de cientistas sugere que o medicamento daclizumab, já utilizado para evitar rejeição em transplantes renais, é efica…